Nursing Care of Infants and Children With Bronchiolitis
DOI:
https://doi.org/10.17140/PNNOJ-2-108Keywords:
Bronchiolitis, Respiratory syncytial virus, Bronchiolitis management, Nursing careAbstract
Bronchiolitis is the most common cause of lower respiratory infection in the first year
of life. It is a leading cause of acute illness and hospitalization for infants and young children
worldwide. Previous studies have demonstrated that at least 1% of children younger than 24
months of age are hospitalized for bronchiolitis. These hospitalizations have been found to consume
a significant amount of health care resources. The primary treatment of bronchiolitis remains
largely supportive with administration of fluids and supplementary oxygen, observation
and mechanical ventilation if needed. Other types of treatment remain controversial. Successful
treatment of this diagnosis requires coordination of care of a multidisciplinary team. Pediatric
nurses and advanced practice pediatric nurses in both primary and acute care clinical settings
can play a major role in educating other health care professionals on the use of Evidence-based
practice and why it is important to decrease costs and improve patients’ outcome by changing
the traditional and habitual use of diagnostic and therapeutic options that are no longer recommended
by the most recent guidelines. The purpose of this review was to identify the best
evidence available for the updated management of infants and children with bronchiolitis. This
updated simplified management of infants with bronchiolitis would result in not only decreasing
the cost of care but also result in a better outcome as mentioned in guidelines according to
the recent literature.
References
Centers for Disease Control and Prevention (CDC). Respira-tory syncytial virus activity-United States, 1999-2000 season. MMWR Morb Mort Wkly Rep. 2000; 49: 1091.
DiNicola LK, Maraqa NF, Custodio HT, Udeani J, Steele RW. Bronchiolitis Clinical Presentation.
Budhiraja S, Verma R, Shields MD. The management of acute bronchiolitis in infants. Paediatrics and Child Health. Elsevier Ltd. 2012; 23: 7. doi: 10.1016/j.paed.2012.11.010
Caracciolo S, Minini C, Colombrita D, Rossi D, Miglietti N, Vettore E. Human meta-pneumovirus infection in young chil-dren hospitalized with acute respiratory tract disease: virologic and clinical features. Pediatr Infect Dis J. 2008; 27(5): 406-412. doi: 10.1097/INF.0b013e318162a164
Centers for Disease Control. Respiratory syncytial virus activ-ity. Centers for Disease Control and Prevention. MMWR. 2010; 59(8): 230-233.
Edelson PJ. Respiratory syncytial virus pneumonia. In: Pedi-atric Emergency Casebook. New York: World Health Communi-cations Inc; 1985: 1-15.
Njoku DB, Kliegman RM. A typical extrapulmonary presen-tations of severe respiratory syncytial virus infection requiring intensive care. Clin Pediatr (Phila). 1993; 32(8): 455-460.
Fitzgerald DA, Kilham HA. Bronchiolitis: assessment and evidence-based management. MJA. 2004; 180: 399–404.
Datsopoulos S. What You Need To Know About: Bronchioli-tis. British Journal of Hospital Medicine. MA Healthcare Ltd. 2014, 75( 9): C141-C144.
Becker S, Soukup J, Yankaskas JR. Respiratory syncytial vi-rus infection of human primary nasal and bronchial epithelial cell cultures and broncho-alveolar macrophages. Am J Respir Cell Mol Biol. 1992; 6(4): 369-374. doi: 10.1165/ajrcmb/6.4.369
Arnold JC, Singh KK, Spector SA, Sawyer MH. Human bo-cavirus: prevalence and clinical spectrum at a children's hospi-tal. Clin Infect Dis. 2006; 43(3): 283-288.
Barclay L. AAP Updates Guidelines on Bronchiolitis in Young Children. Medscape Medical News. Available at http:// www.medscape.com/viewarticle/833884. Accessed November 1, 2014.
Da Dalt L, BressanS, Martinolli F, PerilongoG, Baraldi E. Treatment of bronchiolitis: state of the art. Early Human De-velopment. 2013; 89S1: S31-S36. doi: 10.1016/S0378-3782- (13)70011-2
Nair H, Nokes J, Gessner B, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lan-cet. 2010; 375(9725): 1545-1555. doi: 10.1016/S0140-6736- (10)60206-1
Barclay L. AAP: Palivizumab RSV Prophylaxis Guidelines Updated, July 28, 2014. Medscape Medical News. Pediatrics. 2014; 134: 415-420, e620-e638.
Carroll KN, Gebretsadik T, Griffin MR, et al. Increasing burden andrisk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics. 2008; 122(1): 58-64. doi: 10.1542/peds.2007-2087
Checchia P. Identification and management of severe respi-ratory syncytial virus. American Journal of Health System Phar-macology. 2008; 65(8): S7-S12. doi: 10.2146/ajhp080439
Belderbos M, Houben M, Wilbrink B, et al. Cord blood vi-tamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics. 2011; 127: e1513-el520. doi: 10.1542/ peds.2010-3054
Zentz SE. Care of Infants and Children with Bronchiolitis: A Systematic Review. Journal of Pediatric Nursing. Elsevier Inc. 2011; 26: 519-529. doi: 10.1016/j.pedn.2010.07.008
American Academy of Pediatrics Subcommittee on Diagno-sis and Management of Bronchiolitis. Diagnosis and manage-ment of bronchiolitis. Pediatrics. 2006; 118(4): 1774-1793.
Dawson KP, Long A, Kennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health. 1990; 26(4): 209-211.
Liebelt EL Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med. 1999; 153(5): 525- 530. doi:10.1001/archpedi.153.5.525
Johnson DW, Adair C, Brant R, Holmwood J, Mitchell I. Differences in admission rates of children with bronchiolitis by pediatric and general emergency departments. Pediatrics. 2002; 110(4): e49. doi: 10.1542/peds.110.4.e49
Roqué iFiguls M, Giné-Garriga M, Granados Rugeles C, et al. Chest physiotherapy for acute bronchiolitis in pediatric pa-tients between 0 and 24 months old. Cochrane Database Syst Rev. 2012; 2: CD004873. doi: 10.1002/14651858.CD004873. pub4
Tie SW, Hall GL, Peter S, et al. Home oxygen for children with acute bronchiolitis. Arch Dis Child. 2009; 94(8): 641-643. doi: 10.1136/adc.2008.144709
Jarvis K, Pirvu D, Barbee K, et al. Change to a Standard-ized Airway Clearance Protocol for Children With Bronchiolitis Leads to Improved Care. Journal of Pediatric Nursing. 2014; 29: 252-257. doi: 10.1016/j.pedn.2013.11.007
Bajaj L, Turner CG, Bothner J. A randomized trial of home oxygen therapy from the emergency department for acute bron-chiolitis. Pediatrics. 2006;117(3): 633-640
Flett KB, Breslin K, Bruan PA, et al. Outpatient course and complications associated with home oxygen therapy for mild bronchiolitis. Pediatrics. 2014; 133(5): 769-775.
Luo Z, Liu E, Luo J, et al. Nebulized hypertonic saline/salb-utamol solution treatment inhospitalized children with mild to moderate bronchiolitis. Pediatrics International .2010; 52: 199- 202.
Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2013; 7: CD006458. doi: 10.1002/14651858. CD006458.pub3
Morawetz D, Cheah E, Barton R, Standish J, Connell TG. Is nebulized hypertonic saline useful as an adjunctive treatment for acute bronchiolitis in infants and children less than 24 months of age? Journal of Paediatrics and Child Health. 2011; 47: 922- 926. doi: 10.1111/j.1440-1754.2011.02388.x
Florin TA, Shaw KN, Kittick M, et al. Nebulized hypertonic saline for bronchiolitis in the emergency department: a random-ized clinical trial. JAMA Pediatr. 2014; 168(7): 664-670. doi: 10.1001/jamapediatrics.2013.5306
Ralston S, Hill V, Martinez M. Nebulized hypertonic sa-line without adjunctive bronchodilators for children with bron-chiolitis. Pediatrics. 2010; 126(3): e520-e525. doi: 10.1542/ peds.2009-3105
Seehusen DA, Yancey JR. Effectiveness of Bronchodilators for Bronchiolitis Treatment.Cochrane for Clinicians. A collec-tion of Cochrane for Clinicians published in AFP. Available at : http://www.aafp.org/afp/cochrane Accessed 2015.
Gadomski A, Scribani MB. Bronchodilators for bronchi-olitis. Cochrane Database Syst Rev. 2014; 6: CD001266. doi: 10.1002/14651858.CD001266.pub4
Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Broncho-dilators for bronchiolitis (Cochrane Review). In: The Cochrane Library, Chichester UK: John Wiley & Sons Ltd. 2003; 4.
Skjerven HO, Hunderi JO, Brügmann-Pieper SK, et al. Ra-cemic Adrenaline and Inhalation Strategies in Acute Bronchi-olitis. N Engl J Med. 2013; 368: 2286-2293. doi: 10.1056/NEJ-Moa1301839
Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011; 6: CD003123. doi: 10.1002/14651858.CD003123.pub3
Rochat I, Leis P, Bouchardy M,Oberli C. Chest physiother-apy using passive expiratory techniques does not reduce bron-chiolitis severity: a randomized controlled trial. Eur J Pediatr. 2012; 171: 457-462. doi: 10.1007/s00431-011-1562-y
Somers CC, Ahmad N, Mejias A, et al. Effect of dexametha-sone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial. Pediatr Allergy Immunol. 2009: 20: 477-485. doi: 10.1111/ j.1399-3038.2009.00852.x
Fernandes R, Bialy LM, Vandermeer B, et al. Glucocor-ticoids for acute viral bronchiolitis in infants and young chil-dren. Cochrane Database Syst Rev. 2013; 6: CD004878. doi: 10.1002/14651858.CD004878.pub4
McKiernan C, Chua LC, Visintainer PF, et al. High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr. 2010; 156(4): 634-638. doi: 10.1016/j.jpeds.2009.10.039
Schibler A, Pham TM, Dunster KR, et al. Reduced intuba-tion rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med. 2011; 37(5): 847-852. doi: 10.1007/s00134-011-2177-5
Hough JL, Pham TM, Schibler A. Physiologic effect of high-flow nasal cannula in infants with bronchiolitis. Ped Crit Care Med. 2014; 15(5): e214-e219. doi: 10.1097/ PCC.0000000000000112
Donlan M, Fontela PS, Puligandla PS. Use of continuous positive airway pressure (CPAP) in acute viral bronchiolitis: a systemic review. Pediatr Pulmonol. 2011; 46(8):736-746. doi: 10.1002/ppul.21483
Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Nasal continuous positive airway pressure with heliox in in-fants with acute bronchiolitis. Respir Med. 2006; 100(8): 1458- 1462.
Liet JM, Ducruet T, Gupta V, et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2010; 4: CD006915
Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 2007; 1: CD000181. doi: 10.1002/14651858.CD000181.pub3
American Academy of Pediatrics. In Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
Amirav I, Luder AS, Kruger N, et al. A double-blind, place-bo-controlled randomized trial of montelukast for acute bron-chiolitis. Pediatrics. 2008; 122(6): e1249-e1255. doi: 10.1542/ peds.2008-1744
Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelu-kast for the treatment of respiratory symptoms of post-respira-tory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008; 178(8): 854-860. doi: 10.1164/rccm.200706- 910OC
Remot A, Roux X, Dubuquoy C, et al. Nucleoprotein nano-structures combined with adjuvants adapted to the neonatal im-mune context: a candidate mucosal RSV vaccine. PLoS One. 2012; 7(5): e37722.
Lambert SL, Aslam S, Stillman E, et al. A Novel Respira-tory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cel-lular Immunity In Rodent Models. PLOS ONE. 2015; 1- 24.
Sun Z, Wang Q, Jia R, et al. Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection. Viruses. 2015; 7: 798-819. doi: 10.3390/v7020798
DiVincenzo JP. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses. Anti-vir Ther. 2012; 17(1 Pt B): 213-225. doi: 10.3851/IMP2064.
Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. National Guideline Clearing house. Available at http://guideline.gov/summary/summary.aspx?doc_id=9528 Accessed February 28, 2010.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Pediatrics and Neonatal Nursing (PNN) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
